Fresenius Medical Care AG & Co. KGaA Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$770.00 | Buy/Sell | $636.99 | 13.96% | 9 | $693.31B |
| JNJ | Johnson & Johnson | Outperform |
9
|
$154.64 | Buy/Sell | $174.55 | 9.93% | 3 | $372.17B |
| MRK | Merck | Outperform |
2
|
$131.19 | Buy/Sell | $130.51 | 9.00% | 11 | $332.28B |
| ABBV | AbbVie | Outperform |
9
|
$166.42 | Buy/Sell | $178.42 | 9.66% | 11 | $293.88B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£121.10 | Buy/Sell | £165.99 | 34.64% | 16 | £187.73B |
| ROG | Roche Holding | Hold |
16
|
CHF237.10 | Buy/Sell | CHF307.83 | 14.93% | 9 | CHF191.28B |
| NOVN | Novartis | Hold |
10
|
CHF93.37 | Buy/Sell | CHF105.00 | 15.26% | 9 | CHF190.51B |
| DHR | Danaher | Outperform |
10
|
$265.80 | Buy/Sell | $260.33 | 2.49% | 4 | $196.87B |
| GE | General Electric | Buy |
8
|
$159.89 | Buy/Sell | $144.00 | 12.59% | 3 | $175.02B |
| AMGN | Amgen | Outperform |
4
|
$312.47 | Buy/Sell | $303.65 | 2.41% | 8 | $167.62B |
| PFE | Pfizer | Outperform |
2
|
$28.64 | Buy/Sell | $32.87 | 6.49% | 6 | $162.29B |
| SYK | Stryker Corp | Outperform |
10
|
$334.68 | Buy/Sell | $353.16 | 12.35% | 24 | $127.50B |
| SAN | Sanofi | Outperform |
16
|
89.17€ | Buy/Sell | 102.80€ | 22.80% | 9 | 111.47€B |
| BSX | Boston Scientific | Buy |
11
|
$74.65 | Buy/Sell | $70.14 | 9.85% | 6 | $109.75B |
| GSK | GSK | Outperform |
12
|
£17.75 | Buy/Sell | £17.30 | 12.39% | 12 | £72.39B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.03 | Buy/Sell | $58.15 | 22.64% | 10 | $89.25B |
| 6501 | Hitachi | Outperform |
4
|
¥14.45k | Buy/Sell | ¥11.29k | 10.76% | 0 | ¥13.39T |
| MRK | Merck KGaA | Outperform |
18
|
167.20€ | Buy/Sell | 190.06€ | 9.45% | 4 | 72.69€B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$236.30 | Buy/Sell | $284.47 | 17.44% | 8 | $68.29B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | Buy/Sell | ¥4.74k | 8.96% | 0 | ¥6.48T |
| BIIB | Biogen | Outperform |
10
|
$230.57 | Buy/Sell | $299.62 | 25.12% | 13 | $33.57B |
| SIEMENS | Siemens | Outperform |
16
|
Rp7.19k | Buy/Sell | Rp4.02k | -1.92% | 0 | Rp2.56T |
| CERN | Cerner | - |
13
|
$94.92 | Buy/Sell | $95.00 | -63.34% | 0 | $27.92B |
| PHIA | Koninklijke Philips N.V. | Hold |
18
|
25.87€ | Buy/Sell | 19.42€ | -6.57% | 9 | 24.25€B |
| 4543 | Terumo | Outperform |
18
|
¥5.63k | Buy/Sell | ¥4.97k | -9.46% | 0 | ¥3.76T |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.29 | Buy/Sell | $11.59 | 4.36% | 9 | $18.45B |
| BAX | Baxter International Inc | Hold |
17
|
$35.25 | Buy/Sell | $44.86 | 24.82% | 5 | $17.96B |
| HOLX | Hologic | Outperform |
8
|
$75.02 | Buy/Sell | $81.06 | 12.64% | 3 | $17.51B |
| DVA | DaVita Inc | Hold |
16
|
$139.82 | Buy/Sell | $108.38 | 1.56% | 1 | $12.10B |
| INCY | Incyte | Outperform |
9
|
$57.10 | Buy/Sell | $77.05 | 37.48% | 8 | $12.01B |
| SN. | Smith & Nephew | Outperform |
18
|
£10.24 | Buy/Sell | £16.09 | 58.59% | 10 | £8.73B |
| 3402 | Toray Industries | Outperform |
18
|
¥693.90 | Buy/Sell | ¥891.82 | 34.03% | 0 | ¥1.15T |
| GETI B | Getinge AB | Outperform |
18
|
kr185.50 | Buy/Sell | kr226.10 | 21.83% | 3 | kr63.33B |
| APN | Aspen Pharmacare Holdings | Outperform |
18
|
R229.79 | Buy/Sell | R202.49 | 2.33% | 1 | R102.44B |
| APLS | Apellis Pharmaceuticals | Outperform |
6
|
$41.31 | Buy/Sell | $79.81 | 100.92% | 3 | $5.16B |
| 1066 | Shandong Weigao Group Medical ... | Outperform |
16
|
HK$5.27 | Buy/Sell | HK$11.68 | 35.10% | 2 | HK$24.27B |
| EKTA B | Elekta AB (publ) | Hold |
18
|
kr82.25 | Buy/Sell | kr83.00 | -5.17% | 3 | kr30.26B |
| 8086 | Nipro | Hold |
11
|
¥1.19k | Buy/Sell | ¥0.00 | -7.64% | 0 | ¥174.02B |
| MNK | Mallinckrodt | - |
12
|
$0.08 | Buy/Sell | $1.50 | -100.00% | 0 | $1.02B |
| MD | Pediatrix Medical Group | Hold |
12
|
$7.74 | Buy/Sell | $9.86 | 16.28% | 7 | $748.15M |
| 6376 | Nikkiso | - |
14
|
¥1.27k | Buy/Sell | ¥900.00 | -100.00% | 0 | ¥82.00B |
| AKBA | Akebia Therapeutics | Outperform |
8
|
$1.15 | Buy/Sell | $4.33 | 334.78% | 2 | $293.12M |
| OMER | Omeros | Hold |
11
|
$3.45 | Buy/Sell | $13.00 | -100.00% | 2 | $241.63M |
| XFOR | X4 Pharmaceuticals | Outperform |
4
|
$0.93 | Buy/Sell | $3.26 | 437.63% | 1 | $183.05M |
| 4538 | Fuso Pharmaceutical Industries... | - |
0
|
¥2.23k | Buy/Sell | ¥0.00 | -100.00% | 0 | ¥18.38B |
| DXB | Dimerix |
0
|
$0.38 | Buy/Sell | $0.00 | 52.63% | 0 | $159.38M | |
| 7702 | JMS | - |
18
|
¥519.00 | Buy/Sell | ¥0.00 | -100.00% | 0 | ¥15.03B |
| IFRX | InflaRx N.V. | Outperform |
4
|
$1.63 | Buy/Sell | $9.44 | 356.44% | 2 | $85.38M |
| BLRX | BioLineRx | - |
7
|
₪0.16 | Buy/Sell | ₪1.39 | -100.00% | 0 | ₪302.07M |
| CTSO | Cytosorbents | Outperform |
11
|
$0.97 | Buy/Sell | $4.50 | 209.28% | 1 | $47.35M |
| NEPH | Nephros | Buy |
-12
|
$2.36 | Buy/Sell | $4.50 | 101.27% | 0 | $23.20M |
| AKTX | Akari Therapeutics, Plc | - |
2
|
$1.52 | Buy/Sell | $80.00 | -100.00% | 0 | $9.39M |
| AKSY | Aksys | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% | 0 | $0.00M |